Artivion (AORT) Free Cash Flow Growth (3y) (2013 - 2026)
Artivion (AORT) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 9.23% |
| 10 | Artivion | 1.36 Bn | 1.28 Bn | 80.52 Mn | -65.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.54% |
| Mar 31, 2026 | 8.69% |
| Dec 31, 2025 | -25.63% |
| Sep 30, 2025 | 151.70% |
| Jun 30, 2025 | 46.70% |
| Mar 31, 2025 | -93.62% |
| Dec 31, 2024 | 88.59% |
| Sep 30, 2024 | 48.34% |
| Jun 30, 2024 | 46.87% |
| Mar 31, 2024 | -26.09% |
| Dec 31, 2023 | 35.37% |
| Sep 30, 2023 | -6.33% |
| Jun 30, 2023 | 44.59% |
| Mar 31, 2023 | -357.44% |
| Dec 31, 2022 | -30.83% |
| Sep 30, 2022 | -53.46% |
| Jun 30, 2022 | -93.23% |
| Mar 31, 2022 | -341.35% |
| Dec 31, 2021 | -30.17% |
| Sep 30, 2021 | -41.55% |